Van Cleef Asset Managementinc buys $4,591,596 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Van Cleef Asset Managementinc scooped up 127 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 39,730 shares of Stryker Corporation which is valued at $4,591,596.Stryker Corporation makes up approximately 1.52% of Van Cleef Asset Managementinc’s portfolio.

Other Hedge Funds, Including , Pinnacle Associates Ltd reduced its stake in SYK by selling 1,090 shares or 2.57% in the most recent quarter. The Hedge Fund company now holds 41,296 shares of SYK which is valued at $4,772,579. Stryker Corporation makes up approx 0.10% of Pinnacle Associates Ltd’s portfolio.Investors Capital Advisory Services reduced its stake in SYK by selling 77 shares or 2.06% in the most recent quarter. The Hedge Fund company now holds 3,668 shares of SYK which is valued at $421,160. Stryker Corporation makes up approx 0.08% of Investors Capital Advisory Services’s portfolio.Chesley Taft Associates reduced its stake in SYK by selling 200 shares or 0.18% in the most recent quarter. The Hedge Fund company now holds 113,517 shares of SYK which is valued at $13,284,895. Stryker Corporation makes up approx 1.32% of Chesley Taft Associates’s portfolio. Cwm added SYK to its portfolio by purchasing 1,249 company shares during the most recent quarter which is valued at $146,170. Stryker Corporation makes up approx 0.01% of Cwm’s portfolio.Lynch Associatesin reduced its stake in SYK by selling 450 shares or 1.61% in the most recent quarter. The Hedge Fund company now holds 27,575 shares of SYK which is valued at $3,227,102. Stryker Corporation makes up approx 1.41% of Lynch Associatesin’s portfolio.

Stryker Corporation closed down -0.43 points or -0.37% at $115.23 with 9,39,405 shares getting traded on Thursday. Post opening the session at $115.9, the shares hit an intraday low of $114.41 and an intraday high of $115.9 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.